During the last three months, 16 analysts shared their evaluations of Neurocrine Biosciences NBIX +1.72% Get Free Report , revealing diverse outlooks from bullish to bearish. The following table ...

Jennifer Skaggs had a double lung transplant in 2019. Meeting her donor's family, she fell in love with her donor's brother.

For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time vs placebo.

Neurocrine Biosciences, Inc. announced today that it has scheduled its first quarter 2025 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on May 5, ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

Learn more about whether Neurocrine Biosciences, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ ...

Neurological disorders are among the most disabling illnesses all over the world . Alzheimer rsquo;s disease and Parkinson rsquo;s disease are the two top disorders among them .

A new brain device switched on in Bristol is transforming Parkinson’s treatment—giving one patient a life-changing birthday ...

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...

Parkinson’s disease is often mistaken for routine aging—but ignoring early warning signs can delay crucial treatment. For ...

Foster youth are frequently put on psych meds, an Imprint investigation reveals. State agencies are dropping the ball on ...